Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Mercer, N.; Dulcey, A. E.; Griffiths, G. L.; Qasba, P. K.
  3. Glycobiology. 2012, Mar; 22(3): 379-388.
  1. 2.   Nitric oxide and redox mechanisms in the immune response
  2. Wink, D. A.; Hines, H. B.; Cheng, R. Y. S.; Switzer, C. H.; Flores-Santana, W.; Vitek, M. P.; Ridnour, L. A.; Colton, C. A.
  3. Journal of Leukocyte Biology. 2011, Jun; 89(6): 873-891.
  1. 3.   Crystal Structure of the Catalytic Domain of Drosophila beta 1,4-Galactosyltransferase-7
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Biological Chemistry. 2010, May; 285(20): 15619-15626.
  1. 4.   Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
  2. Stuelten, C. H.; Mertins, S. D.; Busch, J. I.; Gowens, M.; Scudiero, D. A.; Burkett, M. W.; Hite, K. M.; Alley, M.; Hollingshead, M.; Shoemaker, R. H.; Niederhuber, J. E.
  3. Stem Cells. 2010, Apr; 28(4): 649-660.
  1. 5.   Deoxygenated Disaccharide Analogs as Specific Inhibitors of beta 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis
  2. Brown, J. R.; Yang, F.; Sinha, A.; Ramakrishnan, B.; Tor, Y.; Qasba, P. K.; Esko, J. D.
  3. Journal of Biological Chemistry. 2009 284(8): 4952-4959.
  1. 6.   Site-specific linking of biomolecules via glycan residues using Glycosyltransferases
  2. Qasba, P. K.; Boeggeman, E.; Ramakrishnan, B.
  3. Biotechnology Progress. 2008 24(3): 520-526.
  1. 7.   Structure and Function of beta-1,4-Galactosyltransferase
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Current Drug Targets. 2008 9(4): 292-309.
  1. 8.   Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Chatterjee, N.; Yeager, M.; Welch, R.; Chanock, S. J.; Weissfeld, J. L.; Schoen, R. E.; Hayes, R. B.
  3. Carcinogenesis. 2007, Sep; 28(9): 1965-1970.
  1. 9.   Letter to the Glyco-Forum: Catalytic domains of glycosyltransferases with 'add-on' domains
  2. Qasba, P. K.; Ramakrishnan, B.
  3. Glycobiology. 2007, May; 17(5): 7G-9G.
  1. 10.   Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus(mac251)-infected macaques
  2. Hryniewicz, A.; Price, D. A.; Moniuszko, M.; Boasso, A.; Edghill-Spano, Y.; West, S. M.; Venzon, D.; Vaccari, M.; Tsai, W. P.; Tryniszewska, E.; Nacsa, J.; Villinger, F.; Ansari, A. A.; Trindade, C. J.; Morre, M.; Brooks, D.; Arlen, P.; Brown, H. J.; Kitchen, C. M. R.; Zack, J. A.; Douek, D. C.; Shearer, G. M.; Lewis, M. G.; Koup, R. A.; Franchini, G.
  3. Journal of Immunology. 2007, Mar; 178(6): 3492-3504.
  1. 11.   Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method
  2. Boeggeman, E.; Ramakrishnan, B.; Kilgore, C.; Khidekel, N.; Hsieh-Wilson, L. C.; Simpson, J. T.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2007, May-Jun; 18(3): 806-814.
  1. 12.   Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells
  2. Akel, S.; Bertolette, D.; Petrow-Sadowski, C.; Ruscetti, F. W.
  3. Platelets. 2007 18(8): 566-578.
  1. 13.   Role of a single amino acid in the evolution of glycans of invertebrates and vertebrates
  2. Ramakrishnan, B.; Qasba, P. K.
  3. Journal of Molecular Biology. 2007, Jan; 365(3): 570-576.
  1. 14.   Transforming growth factor beta 1 (TGF beta 1) polymorphisms and advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Welch, R.; Chanock, S. J.; Pinsky, P.; Weissfeld, J. L.; Hayes, R. B.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2756S-2756S.
  1. 15.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 16.   Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE(2) and TGF-beta(1)
  2. Ha, C. T.; Waterhouse, R.; Wessells, J.; Wu, J. A.; Dveksler, G. S.
  3. Journal of Leukocyte Biology. 2005, JUN; 77(6): 948-957.
  1. 17.   Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell- factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation
  2. Akel, S.; Petrow-Sadowski, C.; Laughlin, M. J.; Ruscetti, F. W.
  3. Stem Cells. 2003 21(5): 557-567.
  1. 18.   The N-terminal stem region of bovine and human beta 1,4- galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies
  2. Boeggeman, E. E.; Ramakrishnan, B.; Qasba, P. K.
  3. Protein Expression and Purification. 2003 30(2): 219-229.
  1. 19.   Endocrine expression of the active form of TGF-beta 1 in the TGF-beta 1 null mice fails to ameliorate lethal phenotype
  2. Longenecker, G.; Thyagarajan, T.; Nagineni, C. N.; Flanders, K. C.; Factor, V.; Miller, G.; Ward, J. M.; Nalca, A.; Rangnekar, V. M.; Thorgeirsson, S.; Kulkarni, A. B.
  3. Cytokine. 2002 18(1): 43-50.
  1. 20.   Studies on the metal binding sites in the catalytic domain of beta 1,4-galactosyltransferase
  2. Boeggeman, E.; Qasba, P. K.
  3. Glycobiology. 2002 12(7): 395-407.
  1. 21.   beta-1,4-galactosyltransferase and lactose synthase: Molecular mechanical devices
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2002 291(5): 1113-1118.
  1. 22.   Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects
  2. Yang, Y. A.; Dukhanina, O.; Tang, B. W.; Mamura, M.; Letterio, J. J.; MacGregor, J.; Patel, S. C.; Khozin, S.; Liu, Z. Y.; Green, J.; Anver, M. R.; Merlino, G.; Wakefield, L. M.
  3. Journal of Clinical Investigation. 2002 109(12): 1607-1615.
  1. 23.   Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. Ramakrishna, G.; Perella, C.; Birely, L.; Diwan, B. A.; Fornwald, L. W.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2002 179(1): 21-34.
  1. 24.   TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis
  2. Plisov, S. Y.; Yoshino, K.; Dove, L. F.; Higinbotham, K. G.; Rubin, J. S.; Perantoni, A. O.
  3. Development. 2001 128(7): 1045-1057.
  1. 25.   Responsiveness to transforming growth factor-beta (TGF-beta)- mediated growth inhibition is a function of membrane-bound TGF- beta type II receptor in human breast cancer cells
  2. Lynch, M. A.; Petrel, T. A.; Song, H.; Knobloch, T. J.; Casto, B. C.; Ramljak, D.; Anderson, L. M.; DeGroff, V.; Stoner, G. D.; Brueggemeier, R. W.; Weghorst, C. M.
  3. Gene Expression. 2001 9(4-5): 157-171.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel